Self-controlled case series across three US insurance databases in children aged 2-5: febrile seizure incidence was raised 0-1 days after mRNA-1273 vaccination (IRR 2.52, 95% CI 1.35-4.69); after BNT162b2 the IRR (1.41) was not significant.
Meta-analysis
Anderson et al. Febrile seizure risk following monovalent COVID-19 mRNA vaccination in US children aged 2-5 years